ChargePoint Technology, a powder and liquid transfer specialist, has announced the launch of a new robotic material handling solution aimed at increasing s...
Essential Pharma reaches agreement with AGC Biologics for late phase clinical manufacturing of its immunotherapy candidate for the treatment of high-risk...
Cytiva is addressing industry challenges that hinder patient access and broader adoption of autologous CAR T cell therapies with the launch of the new Se...
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, has launched its M...
AstraZeneca intends to build a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates (ADCs), enhancing global supply of its ADC por...
Exploring advanced technologies to help bring novel therapies to patients faster Sartorius to leverage NVIDIA solutions used in live-cell imaging platfo...
Donaldson Company, Inc. (NYSE: DCI), a leading worldwide manufacturer of innovative filtration and separation products and solutions, and PolyPeptide Group...
Ribobay Pharma, a prominent Chinese biopharmaceutical contract research, development, and manufacturing organization (CRDMO), in conjuncti...
Aragen is pleased to announce that its Formulation Manufacturing Facility (FMF) has been awarded Good Manufacturing Practice (GMP) certification by the Dru...
New state-of-the-art research and development (R&D) facility at Ludwigshafen to expand discovery and development of new medicines across core therape...
Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and GenScript Biotech Corpor...
ChargePoint Technology, a specialist in powder and liquid transfer, has invested in a new manufacturing facility dedicated to its single-u...
Biopharmaceutical contract manufacturer SK pharmteco commits to production, testing, and release of Ferring’s U.S. approved ADSTILADRIN® ...
The quest for efficiency without compromising safety and compliance is paramount. This was the central theme of the panel discussion titled "Reimag...
© 2024 Biopharma Boardroom. All Rights Reserved.
